Investigation of potential biomarkers of biochemically recurrent prostate cancer

被引：0
|
作者：
Demidenko, R. [1 ]
Daniunaite, K. [1 ]
Laurinavicius, A. [2 ]
Jankevicius, F. [3 ]
Jarmalaite, S. [1 ]
Lazutka, J. R. [1 ]
机构：
[1] Vilnius State Univ, Div Human Genome Res Ctr, Vilnius, Lithuania
[2] Vilnius State Univ, Dept Pathol Forens Med & Pharmacol, Vilnius, Lithuania
[3] Vilnius State Univ, Dept Urol, Vilnius, Lithuania
来源：
FEBS JOURNAL | 2014年 / 281卷
关键词：
Biomarker; gene expression; prostate cancer;
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
TUE-146
引用
收藏
页码：481 / 481
页数：1
相关论文
共 50 条
  • [31] Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy
    Wong, Gordon W.
    Palazzi-Churas, Kerrin L.
    Jarrard, David F.
    Paolone, David R.
    Graf, Andrew K.
    Hedican, Sean P.
    Wegenke, John D.
    Ritter, Mark A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (02): : 449 - 455
  • [32] Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer
    Sayyid, Rashid K. K.
    Bernardino, Rui
    Al-Daqqaq, Zizo
    Tiwari, Raj
    Cockburn, Jessica
    Vijayakanthan, Shagana
    Leao, Ricardo
    Qaoud, Yazan
    Berjaoui, Mohamad Baker
    Metser, Ur
    Berlin, Alejandro
    Fleshner, Neil E. E.
    BJU INTERNATIONAL, 2023, 132 (06) : 664 - 670
  • [33] Itraconazole as a Noncastrating Treatment for Biochemically Recurrent Prostate Cancer: A Phase 2 Study
    Lee, Mina
    Hong, Haemin
    Kim, Won
    Zhang, Li
    Friedlander, Terence W.
    Fong, Lawrence
    Lin, Amy M.
    Small, Eric J.
    Wei, Xiao X.
    Rodvelt, Tammy J.
    Miralda, Brigid
    Stocksdale, Brian
    Ryan, Charles J.
    Aggarwal, Rahul
    CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : E92 - E96
  • [34] Intermittent Androgen Deprivation for Biochemically Recurrent Prostate Cancer: First Do No Harm
    Serritella, Anthony, V
    Fenton, Sarah E.
    Hussain, Maha
    EUROPEAN UROLOGY FOCUS, 2023, 9 (03): : 407 - 408
  • [35] Phase II trial of acai juice product in biochemically recurrent prostate cancer
    Kessler, Elizabeth Riley
    Su, Lih-Jen
    Yang, Xiaoping
    Lu, Xian
    Morales, Diana
    Anduha, Mary
    Chronister, Nicole
    Wacker, Michael
    Flaig, Thomas W.
    Glode, L. Michael
    Lam, Elaine Tat
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [36] Olaparib for high-risk biochemically recurrent prostate cancer following prostatectomy
    Hintelmann, Katharina
    Boeckelmann, Lukas
    STRAHLENTHERAPIE UND ONKOLOGIE, 2025, 201 (03) : 343 - 345
  • [37] The Potential of MicroRNAs as Prostate Cancer Biomarkers
    Fabris, Linda
    Ceder, Yvonne
    Chinnaiyan, Arul M.
    Jenster, Guido W.
    Sorensen, Karina D.
    Tomlins, Scott
    Visakorpi, Tapio
    Calin, George A.
    EUROPEAN UROLOGY, 2016, 70 (02) : 312 - 322
  • [38] Tetraspanins as potential biomarkers in prostate cancer
    Copeland, Ben
    Ashman, Leonie
    BJU INTERNATIONAL, 2013, 112 : 50 - 50
  • [39] Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial
    Cheung, Eric
    Pinski, Jacek
    Dorff, Tanya
    Groshen, Susan
    Quinn, David I.
    Reynolds, C. Patrick
    Maurer, Barry J.
    Lara, Primo N., Jr.
    Tsao-Wei, Denice D.
    Twardowski, Przemyslaw
    Chatta, Gurkamal
    McNamara, Mark
    Gandara, David R.
    CLINICAL GENITOURINARY CANCER, 2009, 7 (01) : 43 - 50
  • [40] PSMA PET/CT vs. Pelvic MRI in Biochemically Recurrent Prostate Cancer
    Murthy, Vishnu
    Sonni, Ida
    Mehta, Raj
    Chung, Alex
    Unterrainer, Lena
    Hotta, Masatoshi
    Farolfi, Andrea
    Benitez, Cecil
    Armstrong, Wesley
    Doddipalli, Sahith
    Bandara, Anishka
    Valle, Luca
    Kishan, Amar
    Benz, Matthias
    Raman, Steven
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
12345